FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
All articles by Diana Ernst, RPh
Acne Vulgaris Treatment Winlevi Now Available
The approval of Winlevi was based on data from 2 double-blind, vehicle-controlled phase 3 trials in 1440 patients with facial acne vulgaris.
Travel Restrictions Hinder Bimekizumab BLA Review
Bimekizumab is an investigational humanized monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F.
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers
These “pens” use high pressure to force substances into the body.
Inhaled Corticosteroids May Reduce Severity, Frequency of Recurrent Croup
Patients who had more than 5 episodes of croup were more likely to benefit from inhaled corticosteroids.
Low Dose Naltrexone Designated Orphan Drug for Complex Regional Pain Syndrome
Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.
ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season
Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.
Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue
The recall was initiated because the product had prolonged exposure to extremely cold weather during shipment.
Baricitinib Alone Authorized for COVID-19 Under Revised EUA
The update was based on data from the COV-BARRIER study.
Wynzora Cream Now Available for Plaque Psoriasis
Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid.
- Loading...
Loading...
Loading... 
Loading...